We demonstrated that TGF-β1 treatment can not only induce the upregulation of the mesenchymal markers N-cadherin and Vimentin expression, but also increase expression levels of EMT-activating transcription factors, Snail, Slug and ZEB1, in GBM cells in a dose-dependent manner. The gene discussed is VIM; the disease is glioblastoma.